IVA Stock Analysis: Buy, Sell, or Hold?
IVA - Inventiva S.A. American Depository Shares
$3.71
0.20 (5.70%)
▲
5d:
-1.33%
30d:
-28.79%
90d:
-38.98%
BUY
MODERATE Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: May 25, 2026
0d
Get Alerted When IVA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: IVA shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: IVA shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: IVA is currently trading at $3.71, which is considered oversold relative to its 30-day fair value range of $3.70 to $5.02.
Technical Outlook: Technically, IVA is in a strong downtrend. Immediate support is located at $3.49, while resistance sits at $4.02. The stock is showing strong short-term momentum, up 5.7% recently.
Market Sentiment: IVA has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $15.13 (+307.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, IVA is in a strong downtrend. Immediate support is located at $3.49, while resistance sits at $4.02. The stock is showing strong short-term momentum, up 5.7% recently.
Market Sentiment: IVA has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $15.13 (+307.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$3.70 -
$5.02
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
63.2%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+5.7%)
- BULLISH: Trading 307.7% below Wall St target ($15.13)
Trading Range Analysis
30-Day Trading Range
$3.70 -
$5.02
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$3.49
Resistance Level
$4.02
Current Trend
Strong Downtrend
Technical data as of
Jun 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-4.22
Wall Street Target
$15.13
(+307.7%)
Revenue Growth (YoY)
-89.9%
Share & Embed Analysis
Last updated: June 23, 2026 5:43 PM ET
Data refreshes hourly during market hours. Next update: 6:43 PM
Data refreshes hourly during market hours. Next update: 6:43 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IVA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$27 | 56 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$412 | 57 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1022 | 67 BUY |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
